| +380 44 495-10-14 |
rus | eng
|
|
NEOTONATC code: С01Е В06
Active ingredient: sodium phosphocreatine; Neoton is analogous to natural metabolite of human body Phosphocreatine
International name: Phosphocreatine (syn. Creatinphosphate)
Therapeutic indications:
• Intraoperative myocardial ischemia; • Intraoperative limb ischemia • Myocardial metabolic dysfunctions under hypoxic conditions: myocardiosclerosis, senile heart, cardiomyopathy associated with hypertension, chronic ischemic cardiomyopathy; • Skeletal muscle rehabilitation and protection of skeletal muscle from stress cellular damages in sport medicine • Complex therapy of: - acute myocardial infarction; - acute and chronic cardiac failure; - acute stroke, encephalopathies as well as hypoxic, ischemic, traumatic or toxic damages of central nervous system. Package: Neoton 1g №1 Registration in Ukraine UA/9671/01/01 till 13.05.2014 - 1 vial with powder for solution for infusion together with 1 vial with solvent (50 ml of water for injection) and 1 perfusion kit: Neoton 1g №4 Registration in Ukraine UA/9671/01/01 till 13.05.2014 - 4 vials with powder for solution for infusion together with 1 vial with solvent (50 ml of water for injection) and 1 perfusion kit: Shelf-life. 3 years. Storage conditions. Do not store above 25 ºC. |
29.05.2010
21.05.2010
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
Sona-Pharm LLC
Ukraine, 03680 Kyiv Mykoly Grinchenka Str., 4 Теl: +38 044 495 10 14 Fax: +38 044 495 10 15 office@sona-pharm.com.ua |
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||